🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Emerson A. Lim

Grand Rapids Women's Health

ORCID: 0000-0001-7269-349X

Also affiliated with Sidney Kimmel Comprehensive Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020
Top 20%
1.0DataRank
Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Papers

Driven by 8 papers — median percentile 80. Top paper: “A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies”.

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020
Top 20%
1.0DataRank
Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy

The Prostate(2020)10.1002/pros.23948
N/A
0.629DataRank · unranked
13 citations

Samuel Pan, William D. Figg, Zoila A. Lopez‐Bujanda, Jonathan D. Strope, David H. Aggen +6 more

Single-Cell RNAseq Analysis Reveals Robust, Anti-PD-1-Mediated Increase of Immune Infiltrate in Metastatic Castration-Sensitive Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.06.490968
N/A
0DataRank · unranked
2 citations

Aleksandar Obradović, Matthew C. Dallos, Emerson A. Lim, Karie Runcie, Casey R. Ager +15 more

Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer

Cancer Cell(2023)10.1016/j.ccell.2023.10.006
N/A
0DataRank · unranked
77 citations

Aleksandar Obradović, Matthew C. Dallos, Emerson A. Lim, Karie Runcie, Casey R. Ager +16 more

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer(2023)10.1016/j.clgc.2023.02.010
N/A
0DataRank · unranked
58 citations

Michael T. Schweizer, Kim N., Rahul Aggarwal, Neeraj Agarwal, James L. Gulley +9 more

A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study

European Urology(2023)10.1016/j.eururo.2023.01.017
N/A
0DataRank · unranked
56 citations

Michael A. O’Donnell, Jason A. Efstathiou, Marianna Zahurak, Gary L. Rosner, Jeff Smith +36 more

The PRIME-CUT study: A single-arm phase 2 study of ADT with PD-1 blockade and docetaxel in men with metastatic hormone-sensitive prostate cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e17089
N/A
0DataRank · unranked
2 citations

Matthew C. Dallos, Emerson A. Lim, Karie Runcie, Jianhua Hu, Israel Lowy +3 more

Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.03.462951
N/A
0DataRank · unranked
7 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +48 more